Quantitative Susceptibility Mapping of Amyloid-β Aggregates in Alzheimer's Disease with 7T MR.

BACKGROUND PET imaging is an established technique to detect cerebral amyloid-β (Aβ) plaques in vivo. Some preclinical and postmortem data report an accumulation of redox-active iron near Aβ plaques. Quantitative susceptibility mapping (QSM) at high-field MRI enables iron deposits to be depicted with high spatial resolution. OBJECTIVE Aim of this study was to examine whether iron and Aβ plaque accumulation is related and thus, whether 7T MRI might be an additive diagnostic tool to Aβ PET imaging. METHODS Postmortem human Alzheimer's disease (AD) and healthy control (HC) frontal gray matter (GM) was imaged with 7T MRI which resulted in T1 maps and QSM. Aβ plaque load was determined by histopathology. In vivo, 10 Aβ PET-positive AD patients (74.1±6.0a) and 10 Aβ PET-negative HCs (67.1±4.4a) underwent 7T MR examination and QSM maps were analyzed. Severity of cognitive deficits was determined by MMSE. RESULTS Postmortem, the susceptibility of Aβ plaque-containing GM were higher than those of Aβ plaque-free GM (0.011±0.002 versus - 0.008±0.003 ppm, p < 0.001). In vivo, only the bilateral globus pallidus showed significantly higher susceptibility in AD patients compared to HCs (right: 0.277±0.018 versus - 0.009±0.009 ppm; left: 0.293±0.014 versus - 0.007±0.012 ppm, p < 0.0001). The pallidal QSM values were negatively correlated with those of the MMSE (r = - 0.69, p = 0.001). CONCLUSION The postmortem study revealed significant susceptibility differences between the Aβ plaque-containing and Aβ plaque-free GM, whereas in vivo only the QSM values of the globus pallidus differed significantly between AD and HC group. The pallidal QSM values correlated with the severity of cognitive deficits. These findings encourage efforts to optimize the 7T-QSM methodology.

[1]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[2]  Tobias Kober,et al.  MP2RAGE, a self bias-field corrected sequence for improved segmentation and T1-mapping at high field , 2010, NeuroImage.

[3]  C. Rowe,et al.  Comparison of 11C-PiB and 18F-florbetaben for Aβ imaging in ageing and Alzheimer’s disease , 2012, European Journal of Nuclear Medicine and Molecular Imaging.

[4]  Dan Wang,et al.  Age-related iron deposition in the basal ganglia of controls and Alzheimer disease patients quantified using susceptibility weighted imaging. , 2014, Archives of gerontology and geriatrics.

[5]  Yukihiko Fujii,et al.  In Vivo Visualization of Senile‐Plaque‐Like Pathology in Alzheimer's Disease Patients by MR Microscopy on a 7T System , 2008, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[6]  E. Haacke,et al.  Serial susceptibility weighted MRI measures brain iron and microbleeds in dementia. , 2009, Journal of Alzheimer's disease : JAD.

[7]  N. Tzourio-Mazoyer,et al.  Automated Anatomical Labeling of Activations in SPM Using a Macroscopic Anatomical Parcellation of the MNI MRI Single-Subject Brain , 2002, NeuroImage.

[8]  Mark A. Smith,et al.  Iron, zinc and copper in the Alzheimer's disease brain: A quantitative meta-analysis. Some insight on the influence of citation bias on scientific opinion , 2011, Progress in Neurobiology.

[9]  G. Perry,et al.  Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[10]  John Seibyl,et al.  Cerebral amyloid-β PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls: a multicentre phase 2 diagnostic study , 2011, The Lancet Neurology.

[11]  D. Leys,et al.  Iron deposits in post‐mortem brains of patients with neurodegenerative and cerebrovascular diseases: a semi‐quantitative 7.0 T magnetic resonance imaging study , 2014, European journal of neurology.

[12]  Agostinho Santos,et al.  ioinorganic chemistry ron levels in the human brain : A post-mortem study of anatomical egion differences and age-related changes , 2013 .

[13]  Hua-wei Ling,et al.  Correlation of iron in the hippocampus with MMSE in patients with Alzheimer's disease , 2009, Journal of magnetic resonance imaging : JMRI.

[14]  Jon Dobson,et al.  High field magnetic resonance microscopy of the human hippocampus in Alzheimer's disease: Quantitative imaging and correlation with iron , 2012, NeuroImage.

[15]  Frederik Barkhof,et al.  Whole brain analysis of T2* weighted baseline FMRI signal in dementia , 2007, Human brain mapping.

[16]  Ferdinand Schweser,et al.  Toward online reconstruction of quantitative susceptibility maps: Superfast dipole inversion , 2013, Magnetic resonance in medicine.

[17]  Yi Wang,et al.  Calculation of susceptibility through multiple orientation sampling (COSMOS): A method for conditioning the inverse problem from measured magnetic field map to susceptibility source image in MRI , 2009, Magnetic resonance in medicine.

[18]  G. Bartzokis,et al.  In vivo evaluation of brain iron in Alzheimer disease using magnetic resonance imaging. , 2000, Archives of general psychiatry.

[19]  Christian Langkammer,et al.  MRI for Iron Mapping in Alzheimer's Disease , 2013, Neurodegenerative Diseases.

[20]  Dzung L. Pham,et al.  Spatial Models for Fuzzy Clustering , 2001, Comput. Vis. Image Underst..

[21]  H. Gertz,et al.  Individualized quantification of brain β-amyloid burden: results of a proof of mechanism phase 0 florbetaben PET trial in patients with Alzheimer’s disease and healthy controls , 2011, European Journal of Nuclear Medicine and Molecular Imaging.

[22]  Juliane Dinse,et al.  A computational framework for ultra-high resolution cortical segmentation at 7Tesla , 2014, NeuroImage.

[23]  Eveliina Arponen,et al.  Visual assessment of [11C]PIB PET in patients with cognitive impairment , 2010, European Journal of Nuclear Medicine and Molecular Imaging.

[24]  Guy B. Williams,et al.  In Vivo Quantitative Susceptibility Mapping (QSM) in Alzheimer's Disease , 2013, PloS one.

[25]  C. Masters,et al.  Iron-Export Ferroxidase Activity of β-Amyloid Precursor Protein Is Inhibited by Zinc in Alzheimer's Disease , 2010, Cell.

[26]  Jean-Francois Mangin,et al.  R2* mapping for brain iron: associations with cognition in normal aging , 2015, Neurobiology of Aging.

[27]  Wei Wang,et al.  Investigation on positive correlation of increased brain iron deposition with cognitive impairment in Alzheimer disease by using quantitative MR R2′ mapping , 2011, Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban.

[28]  John Seibyl,et al.  Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer's disease: Phase 3 study , 2015, Alzheimer's & Dementia.

[29]  C. Jack,et al.  Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade , 2010, The Lancet Neurology.

[30]  B. Rutt,et al.  Activated iron-containing microglia in the human hippocampus identified by magnetic resonance imaging in Alzheimer disease , 2015, Neurobiology of Aging.

[31]  Brian B. Avants,et al.  Symmetric diffeomorphic image registration with cross-correlation: Evaluating automated labeling of elderly and neurodegenerative brain , 2008, Medical Image Anal..

[32]  Swen Hesse,et al.  Influence of scan duration on the accuracy of β-amyloid PET with florbetaben in patients with Alzheimer’s disease and healthy volunteers , 2012, European Journal of Nuclear Medicine and Molecular Imaging.

[33]  Xiaojun Xu,et al.  Age, gender, and hemispheric differences in iron deposition in the human brain: An in vivo MRI study , 2008, NeuroImage.

[34]  Torsten Rohlfing,et al.  MRI estimates of brain iron concentration in normal aging using quantitative susceptibility mapping , 2011, NeuroImage.

[35]  Jouke Dijkstra,et al.  Postmortem MRI and histology demonstrate differential iron accumulation and cortical myelin organization in early- and late-onset Alzheimer's disease , 2018, Neurobiology of Aging.

[36]  M. Esiri,et al.  Brain burdens of aluminum, iron, and copper and their relationships with amyloid-β pathology in 60 human brains. , 2012, Journal of Alzheimer's disease : JAD.

[37]  A. F. Gietl,et al.  Colocalization of cerebral iron with Amyloid beta in Mild Cognitive Impairment , 2016, Scientific Reports.